pharmaBank is located in Melbourne, capital of the state of Victoria, Australia. Victoria is recognised as an innovative hub for world-class science and offers a dynamic base for biotechnology development and success.
In an international benchmarking study undertaken by the Economist Intelligence Unit in November 2005 (click here to see EIU Report) , Australia was ranked against the US, UK, Germany, Japan, Singapore and India across a range of indicators including clinical trials, the intellectual property system, the regulatory environment, investment and the business environment.  Australia ranked second overall and first as a location to conduct clinical trials, a “testament to the country’s deep roots in scientific, agricultural and medical research”.


MembershipspharmaBank is a member of the BioMelbourne Network, Ausbiotech, and the Australian Private Equity & Venture Capital Association (AVCAL).